← Browse by Condition
Medical Condition
stage iii pancreatic cancer ajcc v8
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, EARLY_Phase 1, Phase 1, Phase 2
NCT04887805 Phase 2
Recruiting
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer
Enrollment
28 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT04005690 EARLY_Phase 1
Recruiting
Targeted Pathway Inhibition in Patients With Pancreatic Cancer
Enrollment
90 pts
Location
United States
Sponsor
OHSU Knight Cancer Institute
NCT05053971 Phase 1, Phase 2
Recruiting
Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
Enrollment
49 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT04550494 Phase 2
Recruiting
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Enrollment
36 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT06454383 Phase 1
Recruiting
Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
Enrollment
19 pts
Location
United States
Sponsor
City of Hope Medical Center